4D Molecular Therapeutics Inc
(FDMT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 189,061 | 275,594 | 249,108 | 275,678 | 236,311 |
| Marketable Securities | 352,885 | 250,317 | 39,124 | 43,986 | 74,032 |
| TOTAL | $552,633 | $535,589 | $296,588 | $328,243 | $317,776 |
| Non-Current Assets | |||||
| PPE Net | 18,761 | 19,464 | 20,126 | 20,738 | 21,295 |
| Investments And Advances | 35,715 | 62,942 | 10,954 | 0 | 0 |
| Other Non-Current Assets | 13,008 | 11,889 | 12,223 | 12,632 | 13,432 |
| TOTAL | $67,484 | $94,295 | $43,303 | $33,370 | $34,727 |
| Total Assets | $620,117 | $629,884 | $339,891 | $361,613 | $352,503 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,431 | 4,217 | 3,515 | 4,713 | 3,493 |
| Accrued Expenses | 12,776 | 9,013 | 12,014 | 10,194 | 6,577 |
| TOTAL | $19,403 | $16,403 | $18,951 | $18,163 | $13,749 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 273 | 130 | 576 |
| Other Non-Current Liabilities | 11,056 | 11,598 | 12,139 | 12,420 | 12,763 |
| TOTAL | $12,374 | $12,920 | $13,111 | $13,516 | $13,610 |
| Total Liabilities | $31,777 | $29,323 | $32,062 | $31,679 | $27,359 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,970 | 51,703 | 49,778 | 42,754 | 42,053 |
| Common Shares | 5 | 5 | 4 | 4 | 4 |
| Retained earnings | -482,681 | -447,728 | -415,327 | -383,044 | -372,788 |
| Other shareholders' equity | -293 | -109 | 16 | 534 | 345 |
| TOTAL | $588,340 | $600,561 | $307,829 | $329,934 | $325,144 |
| Total Liabilities And Equity | $620,117 | $629,884 | $339,891 | $361,613 | $352,503 |